SLC30A10

protein-coding

solute carrier family 30 member 10, the group of Solute carrier family 30

Gene summary

This gene is highly expressed in the liver and is inducible by manganese. Its protein product appears to be critical in maintaining manganese levels, and has higher specificity for manganese than zinc. Loss of function mutations appear to result in a pleomorphic phenotype, including dystonia and adult-onset parkinsonism. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Mar 2012]

MANE transcript

NM_018713.3

Inheritance

AR

ClinVar variants

P:11U:131B:83

Top phenotype

Hypermanganesemia with dystonia 1

gnomAD constraint

pLI —, LoF o/e 0

Max pathogenic AF

—

Genomic locus

chr1:219,685,427-219,959,018

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~273.6 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

cirrhosis - dystonia - polycythemia - hypermanganesemia syndromeSTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0013208

Submitter: PanelApp Australia

cirrhosis - dystonia - polycythemia - hypermanganesemia syndromeSTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0013208

Submitter: Genomics England PanelApp

cirrhosis - dystonia - polycythemia - hypermanganesemia syndromeSTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0013208

Submitter: Labcorp Genetics (formerly Invitae)

cirrhosis - dystonia - polycythemia - hypermanganesemia syndromeSUPPORTIVE

Inheritance Pattern: AR

Disease ID:MONDO:0013208

Submitter: Orphanet

Clinical Genomic Database (CGD)

Hypermanganesemia with dystonia 1AR

Manifestation: Biochemical; Gastrointestinal; Hematologic; Neurologic

Intervention: Hematologic

Rationale: The condition can involve hypermagnesemia, with gastrointestinal, neurologic, and other sequelae, and chelation therapy has been described as beneficial in some individuals

Refs: 11040156; 18087599; 18392750; 21596707; 22341971; 22341972Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to SLC30A10 variants in ClinVar

6 Conditions Cataloged
not providedTotal: 193
Inborn genetic diseasesTotal: 62
Hypermanganesemia with dystonia, polycythemia, and cirrhosisTotal: 37
not specifiedTotal: 10
SLC30A10-related disorderTotal: 7
Congenital ErythrocytosisTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_018713.3. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
75
clinvar
76
missense
1
clinvar
2
clinvar
125
clinvar
8
clinvar
136
nonsense
1
clinvar
2
clinvar
3
clinvar
6
start loss
0
frameshift
3
clinvar
2
clinvar
2
clinvar
7
splice donor/acceptor (+/-2bp)
0
Total56131830225

Highest pathogenic variant AF is 7.217538e-7

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 17 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_018713.3RefSeqNP_061183.24MANE Select
ENST00000366926.4EnsemblENSP00000355893.44MANE Select
NM_001376929.1RefSeqNP_001363858.14Standard
NM_001416004.1RefSeqNP_001402933.13Standard

Model Organisms & Knockout Phenotypes

Observed phenotypic effects in mouse and zebrafish models

Gene / ModelOrganismObserved Phenotype
slc30a10Danio rerio

Structure: nucleate erythrocyte

Quality: increased amount

abnormal

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Zinc homeostasis
  • Transport of bile salts and organic acids, metal ions and amine compounds
  • SLC-mediated transmembrane transport
  • Transport of small molecules
  • Metal ion SLC transporters

Biological Process

  • manganese ion transport
  • zinc ion transport
  • epidermal growth factor receptor signaling pathway
  • negative regulation of neuron apoptotic process
  • positive regulation of ERK1 and ERK2 cascade

Molecular Function

  • manganese ion transmembrane transporter activity
  • protein binding

Cellular Component

  • early endosome
  • Golgi apparatus
  • plasma membrane
  • integral component of membrane
  • recycling endosome

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000366926
Coding exons
4
Length
273221
Individuals with no LoFs
0
Homozygous LoFs
0
Heterozygous LoFs
0
Defined
0
p
0.00
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense1.581972700.7300.00001323119
Missense (PolyPhen)3987.1040.44774967
Synonymous0.1301191210.9850.000006651017
Loss of Function3.20011.90.005.73e-7147

Population LoF Frequency

PopulationCAFp-valueStatus
African00.0absent
Latino/Admixed American00.0absent
Ashkenazi Jewish00.0absent
East Asian00.0absent
Finnish00.0absent
European (Non-Finnish)00.0absent
South Asian00.0absent
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Plays a pivotal role in manganese transport. Manganese is an essential cation for the function of several enzymes, including some crucially important for the metabolism of neurotransmitters and other neuronal metabolic pathways. However, elevated levels of manganese are cytotoxic and induce oxidative stress, mitochondrial dysfunction and apoptosis. Acts as manganese efflux transporter and confers protection against manganese- induced cell death (PubMed:22341972, PubMed:22341971, PubMed:25319704, PubMed:27226609, PubMed:27307044). Also acts as zinc transporter involved in zinc homeostasis. Seems to mediate zinc transport into early endosomes and recycling endosomes to prevent zinc toxicity; the function may be regulated by heterodimerization with other zinc transporters of the SLC30A subfamily. The SLC30A3:SLC30A10 heterodimer is involved in zinc transport-dependent regulation of the EGFR/ERK transduction pathway in endosomes. May be involved in regulation of zinc- dependent senescence of vascular smooth muscle cells (PubMed:22706290, PubMed:22427991, PubMed:26728129). {ECO:0000269|PubMed:22341971, ECO:0000269|PubMed:22341972, ECO:0000269|PubMed:22427991, ECO:0000269|PubMed:25319704, ECO:0000269|PubMed:27226609, ECO:0000305|PubMed:22706290}.;
Disease
DISEASE: Hypermanganesemia with dystonia 1 (HMNDYT1) [MIM:613280]: A metabolic autosomal recessive disorder characterized by dystonia, parkinsonism, extrapyramidal signs, severe hypermanganesemia, polycythemia, and chronic hepatic disease, including steatosis and cirrhosis. {ECO:0000269|PubMed:22341971, ECO:0000269|PubMed:22341972, ECO:0000269|PubMed:25319704}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.125

Intolerance Scores

LoFtool
0.0689
RVIS EVS
-0.4
RVIS percentile EVS
26.53

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
N
Indispensability score
0.0230

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.